Skip to main content
Premium Trial:

Request an Annual Quote

Gene Security Network Reels in $4M in VC Funding

NEW YORK (GenomeWeb News) - Molecular diagnostics company Gene Security Network has raised around $4 million in Series A financing, the firm said yesterday.
 
The round of venture funding was led by Claremont Creek Ventures and included investments from Sequoia Capital, Huntington Reproductive Center, and private investor Marissa Mayer, who is VP of search products and user experience at Google, with a focus on Google Health.
 
GSN plans to use the funds to commercialize its genetic screening technology, called Parental Support, which enables genetic tests for multiple diseases from a single cell and is being clinically tested for pre-implantation genetic diagnosis during in vitro fertilization.
 
The company said it expects its service to become available at IVF centers in the US in 2008.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.